N
Nasz Lekarz Osrodek Badan Klinicznych | Torun, Poland
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Lenalidomide
Tafasitamab
ABP 654
Tazemetostat
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
The participants of this study would have relapsed/refractory follicular lymphoma.Follicular lymphoma is a type of blood cancer. It is referred to as...
Enrolling
Relapsed/Refractory Follicular Lymphoma
Follicular Lymphoma
Combination Product: Rituximab
Drug: Placebo oral tablet
Participants in this study will have diffuse large B-cell lymphoma (DLBCL) that has come back or not gotten better with treatment. The trial will stu...
Active, not recruiting
Diffuse Large B-cell Lymphoma
Drug: Rituximab
Drug: Lenalidomide
This is an open-label, multicentre study too Evaluate the Safety and Pharmacokinetics of a Modified Tafasitamab IV Dosing Regimen Combined with Lenal...
Active, not recruiting
Diffuse Large B Cell Lymphoma
Drug: Lenalidomide
Drug: Tafasitamab
Trial sponsors
E
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems